TRXC - TransEnterix +15% PM marks first time use of 3 mm instruments in robotic pediatric surgery

TransEnterix (TRXC) announces that surgeons at Maastricht University Medical Center+ (or MUMC+) in the Netherlands, have successfully utilized the Senhance® Surgical System and integrate digital laparoscopy with instruments as small as 3 mm for operating on multiple pediatric patients.This becomes first such pediatric surgical program in the world.“This is the first time that 3 mm instruments have been used in robotic pediatric surgery and MUMC+ is the first hospital to initiate a pediatric surgery program with Senhance. We will continue to work with their excellent surgeons to build a successful clinical program and grow the adoption of Senhance in pediatric surgery.” said Anthony Fernando, President and CEO.Previously: TransEnterix jumps 12% as it debuts in robotic surgery with Intelligent Surgical Unit (Sept. 23)

For further details see:

TransEnterix +15% PM, marks first time use of 3 mm instruments in robotic pediatric surgery